Family facts
IDVParent PIIDV797D50492
AgencyFmc Forth Worth
Awarding officeFmc Forth Worth
Awarding agencyDepartment of Justice (DOJ)
Period endJan 3, 2027
IDV obligated$7.5M
Child awards44
Places of performance
StatesIL, MA, MD, OH, TX
Distinctive task orders
1215B50926F00000076 — FY26 PHARMACEUTICALS TAKEDA APRIL-SEPTEMBER
Takeda Pharmaceuticals America, Inc. · $549K · PoP Sep 30, 2026
36C26123N0681 — CINRYZE
Takeda Pharmaceuticals America, Inc. · $511K · PoP Aug 21, 2023
15B50922F00000080 — INMATE BIOLOGIC GAMMAGARD
Takeda Pharmaceuticals America, Inc. · $492K · PoP Oct 30, 2022
15B50926F00000018 — FY26 TAKEDA OCT-NOV
Takeda Pharmaceuticals America, Inc. · $320K · PoP Sep 30, 2026
W81K0221F0186 — OBIZUR EMERGENCY ORDER
Takeda Pharmaceuticals America, Inc. · $249K · PoP Sep 30, 2021
36C26024F0417 — LANADELUMAB-FLYO 150MG/ML INJ, SYRINGE,2ML (TAKHZYRO)
Takeda Pharmaceuticals America, Inc. · $221K · PoP May 19, 2025
36C26124N0588 — TAKHZYRO (LANADELUMAB-FLYO) 150MG/ML INJ,SYRINGE,2ML, NDC: 47783-0646-01
Takeda Pharmaceuticals America, Inc. · $221K · PoP May 15, 2024
15B50926F00000053 — FY26 PHARMACY TAKEDA JAN-SEPT
Takeda Pharmaceuticals America, Inc. · $205K · PoP Feb 28, 2026
15B50923F00000246 — ADVATE AUGUST AND SEPTEMBER
Takeda Pharmaceuticals America, Inc. · $199K · PoP Sep 11, 2023
36C26023F0022 — TAKEDA GAMMAGARD
Takeda Pharmaceuticals America, Inc. · $199K · PoP Sep 30, 2023
36C26025F0061 — BULK ADZYNMA 1500IU INJ,LYPHL
Takeda Pharmaceuticals America, Inc. · $194K · PoP Jan 3, 2026
15B50925F00000146 — TAKEDA FY25
Takeda Pharmaceuticals America, Inc. · $193K · PoP Mar 1, 2025
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.
Data as of · refreshed monthly